Ask AI
H.R. 4669

Advancing Standards in Regenerative Medicine Act

Advancing Standards in Regenerative Medicine Act

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to facilitate the establishment of a public-private Standards Coordinating Body in Regenerative Medicine and Advanced Therapies. The FDA must work with this body to develop standards to support the development and review of regenerative medicine products.

Referred to the Subcommittee on Health.

Rep. Foster, Bill [D-IL-11](D-IL)Sponsor
1 cosponsor1 D
1cosponsors1committees4actions1related bills6subjects
  1. Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  2. IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  3. IntroReferralIntro-H

    Introduced in House

  4. IntroReferral1000

    Introduced in House

Advancing Standards in Regenerative Medicine Act — Informed